Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Grossman William | Interim Chief Medical Officer | P Purchase | — | $1.97 | $10K | filing |
ENGENE THERAPEUTICS (ENGN) insider trading activity (SEC Form 4). Over the trailing 90 days, ENGN insiders filed 1 purchases totalling $10K and 0 sales totalling $0 — net BUYING of $10K. Most recent filing: Sep 24, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Grossman William | Interim Chief Medical Officer | P Purchase | — | $1.97 | $10K | filing |